Sonoma Pharmaceuticals Inc (SNOA)
0.1513
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
0.1513
0.00 (0.00%)
After-Hours: 18:00
Sonoma Pharmaceuticals Debt to Equity Ratio: 0.0066 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0066 |
| September 30, 2023 | 0.0303 |
| June 30, 2023 | 0.0416 |
| March 31, 2023 | 0.054 |
| December 31, 2022 | 0.0027 |
| September 30, 2022 | 0.0348 |
| June 30, 2022 | 0.0596 |
| March 31, 2022 | 0.0929 |
| December 31, 2021 | 0.0526 |
| September 30, 2021 | 0.0686 |
| June 30, 2021 | 0.3694 |
| March 31, 2021 | 0.3554 |
| December 31, 2020 | 0.1064 |
| September 30, 2020 | 0.1175 |
| June 30, 2020 | 0.138 |
| March 31, 2020 | 0.0855 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.0103 |
| June 30, 2019 | 0.0183 |
| March 31, 2019 | 0.0318 |
| December 31, 2018 | 0.0016 |
| September 30, 2018 | 0.0092 |
| June 30, 2018 | 0.0177 |
| March 31, 2018 | 0.0171 |
| December 31, 2017 | 0.0033 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0054 |
| June 30, 2017 | 0.0069 |
| March 31, 2017 | 0.0078 |
| December 31, 2016 | 0.0026 |
| September 30, 2016 | 0.0129 |
| June 30, 2016 | 0.0085 |
| March 31, 2016 | 0.0112 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.0031 |
| March 31, 2015 | 0.0072 |
| December 31, 2014 | 0.0008 |
| September 30, 2014 | 0.0006 |
| June 30, 2014 | 0.0048 |
| March 31, 2014 | 0.0122 |
| December 31, 2013 | 0.0144 |
| September 30, 2013 | 0.7045 |
| June 30, 2013 | 0.517 |
| March 31, 2013 | 0.4741 |
| December 31, 2012 | 0.4981 |
| September 30, 2012 | -5.128 |
| June 30, 2012 | 8.547 |
| March 31, 2012 | -3.732 |
| December 31, 2011 | 19.84 |
| September 30, 2011 | -18.77 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.3694
Maximum
Jun 2021
0.0866
Average
0.054
Median
Mar 2023
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 14.62M |
| Total Liabilities (Quarterly) | 7.926M |
| Shareholders Equity (Quarterly) | 6.692M |
| Current Ratio | 4.067 |
| Net Debt Paydown Yield | 1.62% |